A., D., Gatti, A., E. A., L., R., G., U., K., M., F. (2010). “Patient Acceptability and Tolerability of Fentanyl Pectin Nasal Spray (FPNS) in the Treatment of Breakthrough Cancer Pain (BTCP): Results from a Double-Blind, Double-Dummy, Multiple-Crossover Study of FPNS versus Immediate-Release Morphine Sulphate (IRMS)”.. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? ON BEHALF OF THE FENTANYL NASAL SPRAY STUDY INVESTIGATORS GROUP 6th research congress of the european cancer association for palliative care, glasgow UK.
“Patient Acceptability and Tolerability of Fentanyl Pectin Nasal Spray (FPNS) in the Treatment of Breakthrough Cancer Pain (BTCP): Results from a Double-Blind, Double-Dummy, Multiple-Crossover Study of FPNS versus Immediate-Release Morphine Sulphate (IRMS)”.
GATTI, ANTONIO;
2010-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.